Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 534.5 DKK -1.35% Market Closed
Market Cap: 101B DKK
Have any thoughts about
Genmab A/S?
Write Note

Genmab A/S
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genmab A/S
Total Liabilities & Equity Peer Comparison

Comparables:
ZEAL
ASND
B
BAVA
F
FLUO
BIOPOR

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Genmab A/S
CSE:GMAB
Total Liabilities & Equity
kr38.6B
CAGR 3-Years
20%
CAGR 5-Years
34%
CAGR 10-Years
30%
Zealand Pharma A/S
CSE:ZEAL
Total Liabilities & Equity
kr10.2B
CAGR 3-Years
74%
CAGR 5-Years
53%
CAGR 10-Years
41%
Ascendis Pharma A/S
NASDAQ:ASND
Total Liabilities & Equity
€758.3m
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
44%
B
Bavarian Nordic A/S
CSE:BAVA
Total Liabilities & Equity
kr14.3B
CAGR 3-Years
13%
CAGR 5-Years
40%
CAGR 10-Years
28%
F
Fluoguide AS
STO:FLUO
Total Liabilities & Equity
kr29.6m
CAGR 3-Years
21%
CAGR 5-Years
230%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Total Liabilities & Equity
kr131.5m
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
12%

See Also

What is Genmab A/S's Total Liabilities & Equity?
Total Liabilities & Equity
38.6B DKK

Based on the financial report for Jun 30, 2024, Genmab A/S's Total Liabilities & Equity amounts to 38.6B DKK.

What is Genmab A/S's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
30%

Over the last year, the Total Liabilities & Equity growth was 21%. The average annual Total Liabilities & Equity growth rates for Genmab A/S have been 20% over the past three years , 34% over the past five years , and 30% over the past ten years .

Back to Top